ElectroPhysiology Frontiers

ElectroPhysiology Frontiers is a private Italian medtech company developing a single-shot catheter ablation system for pulmonary vein isolation in patients with atrial fibrillation. Its device is designed to improve lesion durability and reduce arrhythmia recurrence by combining a stabilizing anchor with a circumferential linear array of electrodes that can conform to different anatomies. The platform is being developed for use with both pulsed-field ablation and radiofrequency ablation. The company positions its technology as a simpler, faster, and more reproducible approach to AF ablation for electrophysiologists and healthcare systems. ElectroPhysiology Frontiers appears to be at a pre-clinical development stage and is backed by venture investors in Italy.